Meet Physicians
 
 
     
 

Eye Facts> Eye Diseases

Select a new disease:

Diseases & Conditions: Age Related Macular Degeneration (AMD)

Overview

Age-related macular degeneration (ARMD) is a degenerative condition of the macula (the central retina). It is the most common cause of vision loss in the United States in those 50 or older, and its prevalence increases with age. AMD is caused by hardening of the arteries that nourish the retina. This deprives the sensitive retinal tissue of oxygen and nutrients that it needs to function and thrive. As a result, the central vision deteriorates.

Macular degeneration varies widely in severity. In the worst cases, it causes a complete loss of central vision, making reading or driving impossible. For others, it may only cause slight distortion. Fortunately, macular degeneration does not cause total blindness since it does not affect the peripheral vision.

What is the difference between wet and dry macular degeneration?

AMD is classified as either wet (neovascular) or dry (non-neovascular). About 10% of patients who suffer from macular degeneration have wet AMD. This type occurs when new vessels form to improve the blood supply to oxygen-deprived retinal tissue. However, the new vessels are very delicate and break easily, causing bleeding and damage to surrounding tissue.

Dry macular degeneration, although more common, typically results in a less severe, more gradual loss of vision. The dry type is much more common and is characterized by drusen and loss of pigment in the retina. Drusen are small, yellowish deposits that form within the layers of the retina.

Patient with wet macular degeneration develop new blood vessels under the retina. This causes hemorrhage, swelling, and scar tissue but it can be treated with laser in some cases.

What causes macular degeneration?

Macular degeneration may be caused by variety of factors. Genetics, age, nutrition, smoking, and sunlight exposure may all play a role.

Signs & Symptoms

  • Loss of central vision. This may be gradual for those with the dry type. Patients with the wet type may experience a sudden decrease of the central vision.
  • Difficulty reading or performing tasks that require the ability to see detail.
  • Distorted vision (Straight lines such as a doorway or the edge of a window may appear wavy or bent.)

Detection & Diagnosis

Eye physicians usually diagnose AMD. Vision testing, Amsler grid test, ophthalmoscopy, fundus photography and fluorescein angiography are some common tests performed during a retinal exam.

Treatment

There is no proven medical therapy for dry macular degeneration. However there are several treatments for Wet macular degeneration.

Treatments options for Wet Macular Degeneration

The Wet form of ARMD need to be treated as soon as it has been detected. There are several . Dr. Campbell will discuss all the optins that are out there for you. In fact at times he will suggest a combination of treatments. These different forms of therapy are for those who experience central vision loss from the classic form of Wet ARMD, the leading cause of blindness in people over age 50 in the Western world.

These Therapies include:

Laser Photocoagulation
While this process cannot restore lost vision, it seals the abnormal blood vessels. This prevents further vision deterioration in certain types of Wet Macular Degeneration.
In laser photocoagulation, a laser is used to destroy the abnormal blood vessels under the retina. Since the heat of the laser also destroys overlying healthy retinal tissue, a permanent blind spot will result anywhere the laser is applied. Thus, laser photocoagulation is useful if the abnormal blood vessels are not in the center of vision. If they are in the center however, laser to this area will lead to permanent loss of vision.

Photodynamic Therapy with Visudyne
There is a way to treat abnormal blood vessels in the center of the eye. It’s called Visudyne Therapy.
Even with Visudyne Therapy there may be some loss of vision. However, it’s less severe that laser photocoagulation or no treatment at all. Visudyne therapy cannot restore lost vision.
In Visudyne Therapy, a light-activated drug known as Visudyne (verteporfin for injection) is injected in to the bloodstream. The drug travels in the bloodstream and collects in the abnormal blood vessels, where it is activated by a non-thermal laser (a laser that does not burn the retina). This produces a reaction that closes the abnormal vessels without causing damage to the overlying retina.
Visudyne Therapy is a multi-course treatment. The desired result cannot be achieved with just one or two treatments. Multiple treatments are necessary because leakage often reoccurs and the abnormal blood vessels may return after treatment. However, Visudyne can be reapplied at up to three-month intervals, if necessary. A typical treatment schedule for eligible AMD patients is three treatments in the first year, two times in the second year, and one to two treatments in the third year.

Macugen Injection
Macugen works differently from all other treatments. Macugen blocks a key signal that causes abnormal vessels to grow and leak. By helping to slow the growth of these abnormal blood vessels, Macugen can slow the damage they do to your site.
The goal of therapy with Macugen is to help slow the progression of your disease and preserve your vision. In clinical trials, patients receiving macugen lost less vision on average than patients who did not receive Macugen. However, results may vary from person to person.
This medicine is injected into the eye by Dr. Campbell every 6 weeeks. The medicine has shown to slow the growth of abnormal blood vessels, slowing the damage to your sight. Results may very from patient to patient. Refer to the Macugen website above for further details.

Nutrition and Macular Degeneration

Several recent studies have indicated a strong link between nutrition and the development of macular degeneration. It has been scientifically demonstrated that people with diets high in fruits and vegetables (especially leafy green vegetables) have a lower incidence of macular degeneration. More studies are needed to determine if nutritional supplements can prevent progression in patients with existing disease.

Read Our Disclaimer

 
     
  © 2007 South Texas Retina Consultants • Website development + Hosting by Molecular Solutions